LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures

LGI1-antibody encephalitis is characterised by frequent, multifocal clinical and subclinical seizures

<p>Purpose: To describe clinical and electrographic characteristics of seizures LGI1-antibody encephalitis, and their correlations with two-year outcomes.</p><p> Methods: Video-electroencephalography recordings were performed on a cohort of 16 consecutive patients with LGI1-antibod...

Full description

Bibliographic Details
Main Authors:	Aurangzeb, S, Symmonds, M, Knight, R, Kenett, R, Wehner, T, Irani, S
Format:	Journal article
Published:	Elsevier 2017

Similar Items

Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis.
by: Irani, SR, et al.
Published: (2011)

Pathognomonic seizures in limbic encephalitis associated with anti-LGI1 antibodies.
by: Sen, A, et al.
Published: (2014)

Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?
by: Irani, SR, et al.
Published: (2011)

Intrathecal B cell activation in LGI1-antibody encephalitis
by: Lehmann-Horn, K, et al.
Published: (2020)

LGI1 expression and human brain asymmetry: insights from patients with LGI1-antibody encephalitis
by: Jang, Y, et al.
Published: (2018)

Improving clinical practice with an old friend from the neuroimmunology toolkit: acute corticosteroids in LGI1 antibody encephalitis
by: Irani, SR
Published: (2021)

Immunotherapy-responsive chorea as the presenting feature of LGI1-antibody encephalitis.
by: Tofaris, G, et al.
Published: (2012)

Clinical diagnosis of LGI1 antibody encephalitis in an 83-year-old woman
by: Attwood, JE, et al.
Published: (2021)

Magnetic resonance imaging characteristics of LGI1-antibody and CASPR2-antibody encephalitis
by: Kelly, MJ, et al.
Published: (2024)

The immunogenetics of LGI1- and CASPR2-antibody encephalitis: towards aetiology
by: Binks, S
Published: (2022)

The distinct pattern of movement disorders in Caspr2 and LGI1 antibody associated autoimmune encephalitis
by: Goevert, F, et al.
Published: (2019)

Spontaneous remission without progression to limbic encephalitis in a patient with LGi1 seropositive faciobrachial dystonic seizure
by: Ahmad, S.B., et al.
Published: (2016)

Antibody targets in autoimmune encephalitis
by: Irani, S, et al.
Published: (2010)

Hippocampal functional dynamics are clinically implicated in autoimmune encephalitis with faciobrachial dystonic seizures
by: Nantes, J, et al.
Published: (2018)

EEG-confirmed epileptic activity in a cat with VGKC-complex/LGI1 antibody-associated limbic encephalitis.
by: Pakozdy, A, et al.
Published: (2014)

NMDA receptor antibody encephalitis.
by: Irani, SR, et al.
Published: (2011)

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes
by: Binks, S, et al.
Published: (2017)

CIELO: a randomized, double-blind, placebo-controlled, phase 3 basket study of satralizumab in patients with NMDAR- or LGI1-antibody encephalitis
by: Gelfand, JM, et al.
Published: (2022)

LGI1-antibody associated epilepsy successfully treated in the outpatient setting
by: Uribe-San-Martín, R, et al.
Published: (2020)

NMDA receptor antibody related encephalitis
by: Irani, SR
Published: (2012)

Innovation and optimization in autoimmune encephalitis trials: the design and rationale for the Phase 3, randomized study of satralizumab in patients with NMDAR-IgG-antibody-positive or LGI1-IgG-antibody-positive autoimmune encephalitis (CIELO)
by: Lee, S, et al.
Published: (2024)

Distinct HLA associations of LGI1 and CASPR2-antibody diseases
by: Binks, S, et al.
Published: (2018)

CHARACTERISTIC FACIOBRACHIAL DYSTONIC SEIZURES AS AN IMMUNOTHERAPY-RESPONSIVE PRODROME TO VOLTAGE-GATED POTASSIUM CHANNEL ANTIBODY-ASSOCIATED LIMBIC ENCEPHALITIS
by: Irani, S, et al.
Published: (2010)

Ion channels in EEG: isolating channel dysfunction in NMDA receptor antibody encephalitis
by: Symmonds, M, et al.
Published: (2018)

Acute onset of focal seizures, psychiatric features and confusion: a case of autoimmune encephalitis?
by: Al-Diwani, A, et al.
Published: (2012)

Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy
by: Galban-Horcajo, F, et al.
Published: (2013)

Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy.
by: Galban-Horcajo, F, et al.
Published: (2013)

Immunotherapy responsive neuropathic pain associated with LGI1 and CASPR2 antibodies
by: Ramanathan, S, et al.
Published: (2021)

Pilomotor seizures and status in non-paraneoplastic limbic encephalitis.
by: Wieser, S, et al.
Published: (2005)

Hippocampal epileptogenesis in LGI1, CASPR2 and GABABR antibodies: preliminary findings
by: Romoli, M, et al.
Published: (2020)

Comparative effects of domain-specific human monoclonal antibodies against LGI1 on neuronal excitability
by: Sell, J, et al.
Published: (2023)

Patient-derived antibodies reveal the subcellular distribution and heterogeneous interactome of LGI1
by: Ramirez-Franco, J, et al.
Published: (2022)

Suspected limbic encephalitis and seizure in cats associated with voltage-gated potassium channel (VGKC) complex antibody.
by: Pakozdy, A, et al.
Published: (2013)

Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis.
by: Solomon, T, et al.
Published: (2002)

Hypothermia in VGKC antibody-associated limbic encephalitis.
by: Jacob, S, et al.
Published: (2008)

Comparison of antibody assays in anti-NMDAR encephalitis
by: Gastaldi, M, et al.
Published: (2016)

Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune-associated epilepsy: conceptual definitions
by: Steriade, C, et al.
Published: (2020)

Neurexin-3α: A new antibody target in autoimmune encephalitis
by: Waters, P, et al.
Published: (2016)

Tocilizumab-associated multifocal cerebral thrombotic microangiopathy
by: Jewell, P, et al.
Published: (2016)

Acute seizure risk in patients with encephalitis: development and validation of clinical prediction models from two independent prospective multicentre cohorts
by: Wood, GK, et al.
Published: (2022)